Autoantibodies and antibacterial antibodies: from both sides now

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012

Use of parenteral compared with oral glucocorticoids in early rheumatoid arthritis for chance of being off steroids and escalation of therapy at 1 year.

Annals of the rheumatic diseases·2026

Pharmacodynamic analysis of TYK2 inhibition by deucravacitinib: results from the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus.

Annals of the rheumatic diseases·2026

Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years.

Annals of the rheumatic diseases·2026

The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro.

Annals of the rheumatic diseases·2026

Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial.

Annals of the rheumatic diseases·2026

Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.

Annals of the rheumatic diseases·2026

Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.

Journal of diabetes investigation·2026

Conserved gammaherpesvirus protein kinase counters myeloid cell-specific type I IFN receptor but not IRF-3 expression to promote the establishment of chronic latent infection in the spleen.

Journal of virology·2026

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

Arthritis & rheumatology (Hoboken, N.J.)·2026

The association between psoriasis and body mass index: an observational retrospective study of 184 patients.

Folia medica·2026

Increased interleukin-6 and hepcidin-25 are associated with restless legs syndrome in rheumatoid arthritis patients.

Folia medica·2026

Sporadic inclusion body myositis: overreliance on histology may lead to misdiagnosis.

Folia medica·2026

Related Experiment Videos

Autoantibodies and antibacterial antibodies: from both sides now

Related Concept Videos

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Rheumatological manifestations occurring in patients with diabetes mellitus.

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Use of parenteral compared with oral glucocorticoids in early rheumatoid arthritis for chance of being off steroids and escalation of therapy at 1 year.

Pharmacodynamic analysis of TYK2 inhibition by deucravacitinib: results from the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus.

Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years.

The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro.

Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial.

Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.

Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.

Conserved gammaherpesvirus protein kinase counters myeloid cell-specific type I IFN receptor but not IRF-3 expression to promote the establishment of chronic latent infection in the spleen.

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

The association between psoriasis and body mass index: an observational retrospective study of 184 patients.

Increased interleukin-6 and hepcidin-25 are associated with restless legs syndrome in rheumatoid arthritis patients.

Sporadic inclusion body myositis: overreliance on histology may lead to misdiagnosis.

Related Experiment Videos

Autoantibodies and antibacterial antibodies: from both sides now

Related Concept Videos

Related Articles